This page in English
Laddar profil information

Publikationer

Brain Disorders are Associated With Increased Brain Age
Kasp Consortium, Kaufmann T, Van Der Meer D, Doan Nt, Schwarz E, Lund Mj, et al
BIOLOGICAL PSYCHIATRY 2018;83(9):S238-S239

Brain Variability in Schizophrenia Spectrum Disorder
Kasp Cosortium, Alnaes D, Kaufmann T, Palomera Ac, Schwarz E, Van Der Meer D, et al
BIOLOGICAL PSYCHIATRY 2018;83(9):S422-S423

Associations between central chemokine levels and glial activation in first episode psychosis - a positron emission tomography study
Karolinska Schizophrenia Project, Collste K, Orhan F, Erhardt S, Schwieler L, Flyckt L, et al
EUROPEAN NEUROPSYCHOPHARMACOLOGY 2017;:S722-S722

First-Episode Psychosis Patients Display Increased Plasma IL-18 That Correlates With Cognitive Dysfunctions
Schwieler L, Orhan F, Fatouros-bergman H, Cervenka S, Flyckt L, Farde L, et al
NEUROPSYCHOPHARMACOLOGY 2017;:S220-S221

Reduced TSPO levels in drug-naive first episode psychosis patients as measured using PET and [C-11]PBR28
Collste K, Plaven-sigray P, Fatouros-bergman H, Victorsson P, Schain M, Forsberg A, et al
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 2017;:234-234

PET STUDY OF THALAMIC DOPAMINE D2-RECEPTORS IN DRUG-NAIVE PATIENTS WITH SCHIZOPHRENIA
Ikonen P, Cervenka S, Collste K, Fatouros-bergman H, Matheson G, Sigray Pp, et al
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 2016;:676-676

Surface Area Deficits in Schizophrenia: An ENIGMA Schizophrenia Working Group Meta-analysis
Enigma Schizophrenia Working Grp, Jiang Wh, Walton E, Turner Ja, Glahn Dc, Van Haren N, et al
BIOLOGICAL PSYCHIATRY 2016;79(9):384S-384S

Burden of Informal Care Giving to Patients with Schizophrenia - It's Magnitude and Determinants
Flyckt L, Fatouros-bergman H
EUROPEAN PSYCHIATRY 2015;

Cognitive Performance in Drug-naive First Episode Schizophrenia (FES) Patients
Fatouros-bergman H, Cervenka C, Flyckt L, Edman G, Schwieler L, Ikonen P, et al
EUROPEAN PSYCHIATRY 2015;

ABERRANT TYROSINE TRANSPORT ACROSS THE FIBROBLAST MEMBRANE IN PATIENTS WITH SCHIZOPHRENIA - INDICATIONS OF MATERNAL INHERITANCE
Flyckt L, Edman G
SCHIZOPHRENIA RESEARCH 2012;:S225-S225

ABERRANT TYROSINE TRANSPORT ACROSS THE FIBROBLAST MEMBRANE IN PATIENTS WITH SCHIZOPHRENIA - INDICATIONS OF MATERNAL INHERITANCE
Flyckt L, Edman G
SCHIZOPHRENIA BULLETIN 2011;:85-86

ABERRANT TYROSINE TRANSPORT - A BIOLOGICAL MARKER FOR AN INHERITED SUSCEPTIBILITY TO SCHIZOPHRENIA
Flyckt L, Edman G
EUROPEAN PSYCHIATRY 2009;

Prediction of five-year outcome in first-episode psychoses - does gender really matter?
Flyckt L, Mattsson M, Edman G, Carlsson R, Cullberg J
PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES 2009;:S53-S53

Predicting 5-year outcome in first episode psychosis-construction of a prognostic rating scale
Flyckt L, Mattsson M, Edman G, Carlsson R, Cullberg J
EUROPEAN PSYCHIATRY 2008;:S115-S115

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia
Wiesel Fa, Bjerkenstedt L, Edman G, Flyckt L, Venizelos N
EUROPEAN PSYCHIATRY 2007;:S5-S6

Tyrosine transport in schizophrenia
Wiesel F, Edman G, Flyckt L, Eriksson A, Nyman H, Venizelos N, et al
SCHIZOPHRENIA BULLETIN 2005;31(2):294-294

Amino-acid transport in schizophrenia
Wiesel Fa, Bjerkenstedt L, Flyckt L, Edman G, Venizelos N
EUROPEAN NEUROPSYCHOPHARMACOLOGY 2004;:S139-S140

Cognitive dysfunction in patients with schizophrenia is connected with aberrant tyrosine transport
Wiesel Fa, Edman G, Eriksson A, Flyckt L, Nyman H, Venizelos N, et al
SCHIZOPHRENIA RESEARCH 2004;67(1):126-126

Schizophrenia comprises membrane dysfunction
Wiesel F, Bjerkenstedt L, Flyckt L, Forslund A, Nilsson B, Ohlsson R, et al
SCHIZOPHRENIA RESEARCH 2003;60(1):102-103

Aberrant fingertapping and electromyographical abnormalities in patients with schizophrenia
Flyckt L, Borg K, Borg J, Sydow O, Edman G, Bjerkenstedt L, et al
EUROPEAN PSYCHIATRY 2002;:45S-45S

Aberrant tyrosine transport across the cell membrane in schizophrenia
Wiesel Fa, Flyckt L, Venizelos N, Edman G, Bjerkenstedt L, Hagenfeldt L
EUROPEAN PSYCHIATRY 2002;:75S-75S

A new perspective on the pathophysiology of schizophrenia
Bjerkenstedt L, Edman G, Farde L, Flyckt L, Sillen A, Terenius L, et al
SCHIZOPHRENIA RESEARCH 2002;53(3):79-79

Association study and meta-analysis of a DRD3 gene Ser9Gly variant and schizophrenia
Jonsson Eg, Flyckt L, Burgert E, Crocq Ma, Forslund K, Mattila-evenden M, et al
EUROPEAN PSYCHIATRY 2002;:182S-182S

Muscle histopathology in schizophrenia
Borg K, Flyckt L, Edman G, Ansved T, Bjerkenstedt L, Wiesel Fa
EUROPEAN PSYCHIATRY 2002;:45S-45S

No association between DBH-1021 C/T variant and schizophrenia
Jonsson Eg, Aboujamra R, Schumacher J, Flyckt L, Edman G, Forslund K, et al
AMERICAN JOURNAL OF MEDICAL GENETICS 2002;114(7):853-853

Schizophrenia as a systemic disorder - studies of peripheral and, central biological functions
Flyckt L, Edman G, Bjerkenstedt L, Venizelos N, Hagenfeldt L, Wiesel Fa
EUROPEAN PSYCHIATRY 2002;:219S-219S

Schizophrenia as a systemic disorder - Studies of peripheral and central biological functions
Flyckt L, Edman G, Bjerkenstedt L, Venizelos N, Hagenfeldt L, Wiesel Fa
SCHIZOPHRENIA RESEARCH 2002;53(3):265-266

Muscle biopsy, macro EMG and clinical characteristics in patients with schizophrenia
Flyckt L, Borg J, Borg K, Ansved T, Edman G, Bjerkenstedt L, et al
SCHIZOPHRENIA RESEARCH 2000;41(1):156-156

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and normals
Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel Fa
SCHIZOPHRENIA RESEARCH 1998;29(1-2):181-181

Visa alla publikationer